Investigation of Using Diffusion-Weighted Magnetic Resonance Imaging to Evaluate the Therapeutic Effect of Esophageal Carcinoma Treatment
Authors:
- Chun HanCHChun Han
- Shuchai ZhuSZShuchai Zhu
- Gaofeng ShiGSGaofeng Shi
- Qi WangQWQi Wang
- Hua TianHTHua Tian
- Jie KongJKJie Kong
- Andu ZhangAZAndu Zhang
- 26 February 2014
- journal article
- research article
- Published by S. Karger AG in Oncology Research and Treatment
- Vol. 37 (3) , 112-116
Abstract
Aim: To explore the associations of diffusion-weighted magnetic resonance imaging (DWI) measurements with the therapeutic effect (TE) on and survival of esophageal carcinoma patients treated with chemoradiotherapy (CRT). Methods: From March 2010 to December 2011, 77 patients were prospectively enrolled into a cohort study. DWI was performed at the beginning and 1-3 months after CRT. The immediate post-CRT TE was evaluated according to the Response Evaluation Criteria in Solid Tumors (RECIST). The associations between the disappearance status of hyperintense expression (HE) in DWI and the apparent diffusion coefficient (ADC) of DWI with the complete response (CR) as TE and survival were analyzed. Results: 3 patients were excluded due to the absence of HE in DWI. Analysis of the remaining 74 patients indicated that their ADC values were significantly improved from 1.64 ± 0.48 to 2.65 ± 0.58 mm2/s from pre-CRT to post-CRT (p = 0.000). Both univariate and multivariate Cox model analyses showed that high post-CRT ADC values and the disappearance status of HE associated significantly with the TE (CR rate) and survival. Conclusions: DWI examination could afford useful markers to predict the treatment response as well as the survival of patients with esophageal squamous cell carcinoma. The non-disappearance of HE in DWI and low ADC values after CRT were risk factors.Keywords
This publication has 13 references indexed in Scilit:
- Diffusion-Weighted Magnetic Resonance Imaging Early After Chemoradiotherapy to Monitor Treatment Response in Head-and-Neck Squamous Cell CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Apparent Diffusion Coefficient Values Measured by Diffusion-Weighted Imaging Predict Chemoradiotherapeutic Effect for Advanced Esophageal CancerDigestive Surgery, 2011
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Inflammatory Breast Cancer: Dynamic Contrast-enhanced MR in Patients Receiving Bevacizumab—Initial ExperienceRadiology, 2007
- Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial resultsEuropean Radiology, 2006
- Positron Emission Tomography As an Imaging BiomarkerJournal of Clinical Oncology, 2006
- Preliminary Results on the Influence of Chemoradiation on Apparent Diffusion Coefficients of Primary Rectal Carcinoma Measured by Magnetic Resonance ImagingStrahlentherapie und Onkologie, 2003
- Early Detection of Response to Radiation Therapy in Patients With Brain Malignancies Using Conventional and High b-Value Diffusion-Weighted Magnetic Resonance ImagingJournal of Clinical Oncology, 2003
- Diffusion MRI for prediction of response of rectal cancer to chemoradiationThe Lancet, 2002
- Optimal size criteria of malignant lymph nodes in the treatment planning of radiotherapy for esophageal cancer: Evaluation by computed tomography and magnetic resonance imagingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996